Cargando…
A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma
Lung squamous cell cancer (SCC) and accounts for approximately 20%–30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125098/ https://www.ncbi.nlm.nih.gov/pubmed/35615569 http://dx.doi.org/10.1177/15593258221103373 |
_version_ | 1784711875242491904 |
---|---|
author | Ni, Qingtao Pan, Chi Guo, Qing Wang, Peng Yang, Yan Zhang, Wei Dai, Shengbin |
author_facet | Ni, Qingtao Pan, Chi Guo, Qing Wang, Peng Yang, Yan Zhang, Wei Dai, Shengbin |
author_sort | Ni, Qingtao |
collection | PubMed |
description | Lung squamous cell cancer (SCC) and accounts for approximately 20%–30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent to the great vessels. I-125 is an ideal brachytherapy for lung SCC patients with large masses who lost the chance of operation. I-125 is an adjuvant therapy, combined with chemotherapy and molecular targeting therapy might serve to improve the prognosis of lung SCC patients. |
format | Online Article Text |
id | pubmed-9125098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-91250982022-05-24 A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma Ni, Qingtao Pan, Chi Guo, Qing Wang, Peng Yang, Yan Zhang, Wei Dai, Shengbin Dose Response Clinical Case Lung squamous cell cancer (SCC) and accounts for approximately 20%–30% of all lung cancers. Surgery, chemotherapy and radiotherapy are the main treatments for lung SCC patients. A case with lung SCC patient who was treated using iodine 125 seeds (I-125) because the location of the tumor was adjacent to the great vessels. I-125 is an ideal brachytherapy for lung SCC patients with large masses who lost the chance of operation. I-125 is an adjuvant therapy, combined with chemotherapy and molecular targeting therapy might serve to improve the prognosis of lung SCC patients. SAGE Publications 2022-05-19 /pmc/articles/PMC9125098/ /pubmed/35615569 http://dx.doi.org/10.1177/15593258221103373 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Clinical Case Ni, Qingtao Pan, Chi Guo, Qing Wang, Peng Yang, Yan Zhang, Wei Dai, Shengbin A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma |
title | A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma |
title_full | A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma |
title_fullStr | A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma |
title_full_unstemmed | A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma |
title_short | A Case of Iodine 125 Seeds (I-125) Responding to Lung Squamous Cell Carcinoma |
title_sort | case of iodine 125 seeds (i-125) responding to lung squamous cell carcinoma |
topic | Clinical Case |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125098/ https://www.ncbi.nlm.nih.gov/pubmed/35615569 http://dx.doi.org/10.1177/15593258221103373 |
work_keys_str_mv | AT niqingtao acaseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT panchi acaseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT guoqing acaseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT wangpeng acaseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT yangyan acaseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT zhangwei acaseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT daishengbin acaseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT niqingtao caseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT panchi caseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT guoqing caseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT wangpeng caseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT yangyan caseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT zhangwei caseofiodine125seedsi125respondingtolungsquamouscellcarcinoma AT daishengbin caseofiodine125seedsi125respondingtolungsquamouscellcarcinoma |